We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
InVitria Optimizes Hybridoma Cell Culture with new Product Zap-Hybridoma
Product News

InVitria Optimizes Hybridoma Cell Culture with new Product Zap-Hybridoma

InVitria Optimizes Hybridoma Cell Culture with new Product Zap-Hybridoma
Product News

InVitria Optimizes Hybridoma Cell Culture with new Product Zap-Hybridoma


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "InVitria Optimizes Hybridoma Cell Culture with new Product Zap-Hybridoma"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

InVitria’s launch of Zap-Hybridoma provides a solution for hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver purification of the target product.

Zap-Hybridoma was developed by InVitria’s Cell Culture Development team as an answer to many of the challenges facing scientists working with hybridoma cell culture.

“Not only can Zap-Hybridoma increase productivity, it delivers consistent results and allows hybridoma cells to more quickly adapt away from FBS (fetal bovine serum),” said Dr. Steve Pettit, InVitria’s Director of Cell Culture Development. “We tested Zap-Hybridoma in six of the leading commercial hybridoma media on the market today and observed faster cell growth, a 50% average increase in maximum cell density and increased monoclonal antibody yield when compared to the recommended use of the manufacturer.”

“Zap-Hybridoma is an innovation InVitria is proud to bring to its customers so they can achieve better performance more consistently,” said Scott Deeter, InVitria President and CEO. “We developed Zap-Hybridoma to give users an IgG free alternative to FBS without sacrificing performance.”
Advertisement